Together we will beat cancer

Donate

Fears breast cancer progress could stall due to COVID-19 backlog

Around 10,600 fewer breast cancer patients have started treatment in the last year in England, as experts fear hard-won progress could slow.

Read More

New hormone treatment for advanced prostate cancer made available in England

Hormone treatment enzalutamide will now be offered as an alternative combined treatment option for some adults with prostate cancer on the NHS in England.

Read More

A bug in the system – the difficulties of linking the microbiome to cancer aetiology

Teasing apart causation from correlation is vital if we are to understand whether the gut microbiome changes the risk of cancer or whether cancer changes the gut microbiome

Read More

Cancer clinical trials – learning lessons from the COVID-19 pandemic

After a very difficult year for cancer clinical trials, we look to the future and ask what positive lessons can be learnt

Read More

Partnership in a pandemic: how Credit Suisse delivered an incredible Charity of the Year partnership despite lockdown

We explore how our partner, Credit Suisse, adapted to significant changes in the fundraising environment to exceed its original targets for the partnership.

Read More

Peer-to-peer match-funding initiative raises over £4 million for cancer research

The Cancer Research UK Challenge Fund, which we launched in the initial throes of the pandemic, will help to ensure we can continue funding vital research.

Read More

Cancer Research UK spin-out goes public, ready to invest more in precision T cell therapies

Cancer Research UK’s spinout, Achilles Therapeutics plc (‘Achilles’), has raised $175.5 million through the closing of its initial public offering (IPO).

Read More

Catch up on Behind the Science 2021 – From funding stream to blood stream: Is drug development moving fast enough?

This year’s event took place virtually on Wednesday 12 May. Watch or listen back now.

Read More

‘Will cancer make me infertile?’ – That Cancer Conversation

This entry is part 1 of 1 in the series That Cancer Conversation

For the first episode of our new podcast, we explore cancer and infertility.

Read More

Mitochondrial DNA in cancer: small genome, big impact

Payam Gammage believes understanding the mutations in mtDNA could reveal indicators of cancer prognosis and a new focus for therapeutics.

Read More